Resource Library

Revealing a Deeper Understanding of Immuno-Oncology

Video resources on immuno-oncology

Please see below for videos about immuno-oncology pathways, unmet needs in the management of bladder cancer, and expert points of view on the treatment and management of imAEs.

X


imAEs: Introduction

ic-drawer

Chapters: 3

Total Time: 01:44

X


imAEs: Endocrine system

ic-drawer

Chapters: 5

Total Time: 07:28

X


imAEs: Gastrointestinal tract

ic-drawer

Chapters: 6

Total Time: 06:33

X


imAEs: Kidneys

ic-drawer

Chapters: 6

Total Time: 05:26

X


imAEs: Liver

ic-drawer

Chapters: 6

Total Time: 04:38

X


imAEs: Lungs

ic-drawer

Chapters: 5

Total Time: 04:03

X


imAEs: Skin

ic-drawer

Chapters: 8

Total Time: 07:50

X


What is the rationale for combining PD-L1 inhibition and CTLA-4 inhibition?

ic-drawer

Total Time: 02:55

X


Inhibiting the PD-1/PD-L1 pathway

ic-drawer

Total Time: 02:20

X


CTLA-4 inhibition

ic-drawer

Total Time: 02:17

X


Activating the OX40/OX40L axis

ic-drawer

Total Time: 02:15

X


Unmet needs in the management of bladder cancer

ic-drawer

Total Time: 15:54

Downloadable material

Online resources

PD-1=programmed cell death-1; PD-L1=programmed cell death ligand-1; CTLA-4=cytotoxic T-lymphocyte antigen 4; NSCLC=non-small cell lung cancer.